All news

22 MAR 2021

Exclusive negotiations for the acquisition of a start-up in the field of spinal surgery

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), announces that it has entered exclusive negotiations with a view to the acquisition of 100% of the capital of a European start-up specialized in the design, manufacture and sale of implants and instruments for spinal surgery.

Press releases
22 MAR 2021

Approval of the General Meeting’s resolutions Solid cash position to continue development

The Combined General Meeting of Spineway’s shareholders was held upon first notice of meeting on Monday, 8 March 2020, behind closed doors, at the Company’s registered office. The number of shares held by the shareholders represented amounted to 3 232 993 768 shares, i.e., a turnout of 25.79%.

Press releases
25 FEB 2021

Signature of a partnership with Tsunami Medical

Spineway announces the signature of a partnership with the Italian company Tsunami Medical, pioneer in innovative 3D-printed solutions, for the sale of Twin Peaks interbody cages produced with 3D printers.

Press releases
11 FEB 2021

Continued expansion in Asia

Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.

Press releases
28 JAN 2021

October 27 2020 – 2020 half-year results

Le Conseil d’Administration de Spineway, réuni le 26 Octobre 2020 sous la Présidence de Stéphane Le Roux, a arrêté les comptes semestriels 2020.

Press releases
28 JAN 2021

May 23 2020 Government-backed loan of €1.13M secured / Reserved capital increase of €4.6M implemented

Spineway, specialist in designing innovative surgical implants and instruments for treating severe disorders of the spinal column, expects the gradual return of spinal surgeries worldwide. In order to meet the needs of this recovery, the company has welcomed some of its employees back on the premises after implementing the new health and safety rules required following the lifting of the COVID-19 stay-at-home order to lessen the risk of the virus spreading to employees. For now, employees whose jobs are conducive to working remotely remain at home. This will change as needs evolve due to the return to activity and the health authorities’ recommendations.

Press releases
28 JAN 2021

January 21 2021 2020 revenue

Spineway, specialized in innovative implants for the treatment of disorders of the spinal column (spine), showed a sharp increase in sales for the month of December 2020 (+30% compared with December 2019), allowing it to post revenue of €1 068K for the fourth quarter, up 21% compared with the third quarter of 2020. This positive dynamism brough the Group’s annual revenue to €3 380K and decreased the gap with 2019 (-33%) for a year that was deeply affected by the COVID crisis.

Press releases
28 JAN 2021

September 9 2020 Launch of MISTI, a modular platform for instruments

Spineway, specialized in the treatment of severe disorders of the spine, announces the launch of a new concept: MISTI (acronym for Minimally Invasive Spine Total Instrumentation).

Press releases
28 JAN 2021

April 23 2020 Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments

Spineway, specialist in designing innovative surgical implants and instruments for treating severe disorders of the spinal column, announces the signature of an exclusive agreement for the distribution of its products in Japan with MURANAKA Medical Instruments.

Press releases
LOADING